Log in to save to my catalogue

Standard therapy or additionally radioactive iodine (131I) therapy; which will stop the recurrence o...

Standard therapy or additionally radioactive iodine (131I) therapy; which will stop the recurrence o...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_journals_3050821060

Standard therapy or additionally radioactive iodine (131I) therapy; which will stop the recurrence of glioblastoma multiforme (GBM)?

About this item

Full title

Standard therapy or additionally radioactive iodine (131I) therapy; which will stop the recurrence of glioblastoma multiforme (GBM)?

Publisher

Wydawnictwo Via Medica

Journal title

Endokrynologia polska, 2024-01, Vol.75 (2), p.130-139

Language

English

Formats

Publication information

Publisher

Wydawnictwo Via Medica

More information

Scope and Contents

Contents

Glioblastoma multiforme (GBM) is the most aggressive malignant brain tumour. The average survival time for a patient diagnosed with GBM, using standard treatment methods, is several months. Authors of the article pose a direct question: Is it possible to treat GBM solely with radioactive iodine (¹³¹I) therapy without employing the sodium iodide sym...

Alternative Titles

Full title

Standard therapy or additionally radioactive iodine (131I) therapy; which will stop the recurrence of glioblastoma multiforme (GBM)?

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_proquest_journals_3050821060

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_journals_3050821060

Other Identifiers

ISSN

0423-104X

E-ISSN

2299-8306

DOI

10.5603/ep.98240

How to access this item